Quality of Life in Schizophrenic Patients

Completed

• Conditions: Schizophrenia

• Registration Number: NCT00597168
• Lead Sponsor: AstraZeneca

Brief Summary

This is a non-interventional study evaluating quality of life in schizophrenic patients treated with atypical antipsychotics, in the ambulatory setting. This is a 9-month, observational, multicentric prospective study.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-10
• Study First Submitted: 2007-11-28
• Study First Submitted QC: 2008-01-16
• Study First Posted: 2008-01-17
• Primary Completion: 2009-10
• Study Completion: 2009-10
• Status Verified: 2010-06
• Last Update Submitted: 2010-06-08
• Last Update Posted: 2010-06-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 124

Inclusion Criteria

• Patients diagnosed with Schizophrenia treated with atypical antipsychotics (ambulatory patients).

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change from baseline of QOL assessed by the SWN-K after 9 months of treatment with AAPs.	9 months

Trial Locations

Locations (1)

Research Site; 🇧🇪 Woluwe-Saint-Lambert, Belgium